{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:08:13Z","timestamp":1788858493539,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Imaging and Behavior"],"DOI":"10.1007\/s11682-026-01181-3","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T07:14:19Z","timestamp":1784790859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated CSF GAP-43 is associated with reduced cerebral glucose metabolism and cognitive impairment in individuals with mild cognitive impairment"],"prefix":"10.1007","volume":"20","author":[{"given":"Hani Moslem","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Fawzi","family":"Al-Hussainy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M.","family":"Rekha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Kundlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kattela","family":"Chennakesavulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Manu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasur","family":"Rizaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sada Ghalib","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"Alwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"3","key":"1181_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/brain\/awx365","volume":"141","author":"M Albert","year":"2018","unstructured":"Albert, M., Zhu, Y., Moghekar, A., Mori, S., Miller, M. I., Soldan, A., et al. (2018). Predicting progression from normal cognition to mild cognitive impairment for individuals at 5 years. Brain, 141(3), 877\u201387.","journal-title":"Brain"},{"key":"1181_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-7508-8_3","volume-title":"Mild cognitive impairment\u2014an early stage of Alzheimer\u2019s disease?","author":"O Almkvist","year":"1998","unstructured":"Almkvist, O., Basun, H., B\u00e4ckman, L., Herlitz, A., Lannfelt, L., & Small, B. (1998). Mild cognitive impairment\u2014an early stage of Alzheimer\u2019s disease? Springer."},{"issue":"1","key":"1181_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03904-9","volume":"24","author":"A Ariaei","year":"2024","unstructured":"Ariaei, A., Ghorbani, A., Habibzadeh, E., Moghaddam, N., Chegeni Nezhad, N., Abdoli, A., et al. (2024). Investigating the association between the GAP-43 concentration with diffusion tensor imaging indices in Alzheimer\u2019s dementia continuum. BMC Neurology, 24(1), Article 397. https:\/\/doi.org\/10.1186\/s12883-024-03904-9","journal-title":"BMC Neurology"},{"key":"1181_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2919-z","author":"A Ashraf","year":"2014","unstructured":"Ashraf, A., Fan, Z., Brooks, D., & Edison, P. (2014). Cortical hypermetabolism in MCI subjects: A compensatory mechanism? European Journal of Nuclear Medicine and Molecular Imaging. https:\/\/doi.org\/10.1007\/s00259-014-2919-z","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"9","key":"1181_CR5","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/jpp\/rgae066","volume":"76","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi, A. (2024). Immunotherapy in Alzheimer\u2019s disease: Focusing on the efficacy of gantenerumab on amyloid-\u03b2 clearance and cognitive decline. Journal of Pharmacy and Pharmacology, 76(9), 1115\u20131131. https:\/\/doi.org\/10.1093\/jpp\/rgae066","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"1","key":"1181_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","volume":"17","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi, A. (2024). The duality of amyloid-\u03b2: Its role in normal and Alzheimer\u2019s disease states. Molecular Brain, 17(1), 44. https:\/\/doi.org\/10.1186\/s13041-024-01118-1","journal-title":"Molecular Brain"},{"issue":"2","key":"1181_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s12031-025-02333-8","volume":"75","author":"A Azargoonjahromi","year":"2025","unstructured":"Azargoonjahromi, A., Eivazi, M., Nasiri, H., Tarhriz, V., & Payandeh, Z. (2025). For the Alzheimer\u2019s Disease Neuroimaging I. Elevated CSF GAP-43 in Mild Cognitive Impairment Linked to Cognitive Impairment Through Increased Amyloid-\u03b2 Accumulation, with a Shift to Reduced Amyloid-\u03b2 Accumulation in Alzheimer\u2019s Disease. Journal of Molecular Neuroscience, 75(2), 39. https:\/\/doi.org\/10.1007\/s12031-025-02333-8","journal-title":"Journal of Molecular Neuroscience"},{"issue":"6","key":"1181_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow, K., & Zetterberg, H. (2018). Biomarkers for Alzheimer\u2019s disease: Current status and prospects for the future. Journal of internal medicine, 284(6), 643\u2013663.","journal-title":"Journal of internal medicine"},{"issue":"3","key":"1181_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41583-019-0132-6","volume":"20","author":"DA Butterfield","year":"2019","unstructured":"Butterfield, D. A., & Halliwell, B. (2019). Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nature Reviews Neuroscience, 20(3), 148\u2013160.","journal-title":"Nature Reviews Neuroscience"},{"issue":"1","key":"1181_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tem.2012.11.003","volume":"24","author":"D Cai","year":"2013","unstructured":"Cai, D. (2013). Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends In Endocrinology And Metabolism, 24(1), 40\u201347. https:\/\/doi.org\/10.1016\/j.tem.2012.11.003","journal-title":"Trends In Endocrinology And Metabolism"},{"issue":"8","key":"1181_CR11","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1007\/s00259-020-05175-1","volume":"48","author":"SP Caminiti","year":"2021","unstructured":"Caminiti, S. P., Sala, A., Presotto, L., Chincarini, A., Sestini, S., Perani, D., et al. (2021). Validation of FDG-PET datasets of normal controls for the extraction of SPM-based brain metabolism maps. European Journal of Nuclear Medicine and Molecular Imaging, 48(8), 2486\u201399. https:\/\/doi.org\/10.1007\/s00259-020-05175-1","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"1181_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pharmthera.2018.11.006","volume":"195","author":"Y Chen","year":"2019","unstructured":"Chen, Y., Fu, A. K., & Ip, N. Y. (2019). Synaptic dysfunction in Alzheimer\u2019s disease: Mechanisms and therapeutic strategies. Pharmacology & therapeutics, 195, 186\u2013198.","journal-title":"Pharmacology & therapeutics"},{"issue":"1","key":"1181_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s13311-016-0481-z","volume":"14","author":"SE Counts","year":"2017","unstructured":"Counts, S. E., Ikonomovic, M. D., Mercado, N., Vega, I. E., & Mufson, E. J. (2017). Biomarkers for the Early Detection and Progression of Alzheimer\u2019s Disease. Neurotherapeutics, 14(1), 35\u201353. https:\/\/doi.org\/10.1007\/s13311-016-0481-z","journal-title":"Neurotherapeutics"},{"issue":"4","key":"1181_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1590\/1980-57642015dn94000385","volume":"9","author":"AMN Coutinho","year":"2015","unstructured":"Coutinho, A. M. N., Porto, F. H. G., Zampieri, P. F., Otaduy, M. C., Perroco, T. R., Oliveira, M. O., et al. (2015). Analysis of the posterior cingulate cortex with [18F]FDG-PET and Naa\/mI in mild cognitive impairment and Alzheimer\u2019s disease: Correlations and differences between the two methods. Dement Neuropsychol, 9(4), 385\u2013393. https:\/\/doi.org\/10.1590\/1980-57642015dn94000385","journal-title":"Dement Neuropsychol"},{"issue":"2","key":"1181_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.nbd.2008.10.003","volume":"35","author":"R Craig-Schapiro","year":"2009","unstructured":"Craig-Schapiro, R., Fagan, A. M., & Holtzman, D. M. (2009). Biomarkers of Alzheimer\u2019s disease. Neurobiology of disease, 35(2), 128\u2013140.","journal-title":"Neurobiology of disease"},{"issue":"S5","key":"1181_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/alz.044098","volume":"16","author":"K Dhiman","year":"2020","unstructured":"Dhiman, K., Villemagne, V. L. L., Eratne, D., Graham, P. L., Fowler, C. J., Bourgeat, P., et al. (2020). Elevated levels of synaptic protein GAP-43 associate with brain tauopathy, atrophy and cognition in Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia, 16(S5), Article e044098. https:\/\/doi.org\/10.1002\/alz.044098","journal-title":"Alzheimer's & Dementia"},{"issue":"1","key":"1181_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1152\/physrev.00062.2017","volume":"99","author":"GA Dienel","year":"2019","unstructured":"Dienel, G. A. (2019). Brain glucose metabolism: Integration of energetics with function. Physiological reviews, 99(1), 949\u20131045.","journal-title":"Physiological reviews"},{"key":"1181_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073627","author":"A Faria-Pereira","year":"2022","unstructured":"Faria-Pereira, A., & Morais, V. A. (2022). Synapses: The brain\u2019s energy-demanding sites. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms23073627","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"1181_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44374-w","volume":"15","author":"N Franzmeier","year":"2024","unstructured":"Franzmeier, N., Dehsarvi, A., Steward, A., Biel, D., Dewenter, A., Roemer, S. N., et al. (2024). Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer\u2019s disease. Nature Communications, 15(1), Article 202. https:\/\/doi.org\/10.1038\/s41467-023-44374-w","journal-title":"Nature Communications"},{"issue":"1","key":"1181_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00740-0","volume":"13","author":"A Gharbi-Meliani","year":"2021","unstructured":"Gharbi-Meliani, A., Dugravot, A., Sabia, S., Regy, M., Fayosse, A., Schnitzler, A., et al. (2021). The association of APOE \u03b54 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study. Alzheimer\u2019s Research & Therapy, 13(1), Article 5. https:\/\/doi.org\/10.1186\/s13195-020-00740-0","journal-title":"Alzheimer's Research & Therapy"},{"issue":"2","key":"1181_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/alz.12694","volume":"19","author":"A Gustavsson","year":"2023","unstructured":"Gustavsson, A., Norton, N., Fast, T., Fr\u00f6lich, L., Georges, J., Holzapfel, D., et al. (2023). Global estimates on the number of persons across the Alzheimer\u2019s disease continuum. Alzheimer\u2019s & Dementia, 19(2), 658\u2013670.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"3","key":"1181_CR22","doi-asserted-by":"publisher","DOI":"10.4155\/fsoa-2018-0069","volume":"5","author":"S Hatashita","year":"2019","unstructured":"Hatashita, S., & Wakebe, D. (2019). Amyloid \u03b2 deposition and glucose metabolism on the long-term progression of preclinical Alzheimer\u2019s disease. Future Science OA, 5(3), Article Fso356. https:\/\/doi.org\/10.4155\/fsoa-2018-0069","journal-title":"Future Science OA"},{"issue":"1","key":"1181_CR23","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1006\/nimg.2002.1208","volume":"17","author":"K Herholz","year":"2002","unstructured":"Herholz, K., Salmon, E., Perani, D., Baron, J. C., Holthoff, V., Fr\u00f6lich, L., et al. (2002). Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. NeuroImage, 17(1), 302\u201316. https:\/\/doi.org\/10.1006\/nimg.2002.1208","journal-title":"NeuroImage"},{"issue":"2","key":"1181_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.pscychresns.2006.12.003","volume":"155","author":"A Hunt","year":"2007","unstructured":"Hunt, A., Sch\u00f6nknecht, P., Henze, M., Seidl, U., Haberkorn, U., & Schr\u00f6der, J. (2007). Reduced cerebral glucose metabolism in patients at risk for Alzheimer\u2019s disease. Psychiatry Research: Neuroimaging, 155(2), 147\u201354. https:\/\/doi.org\/10.1016\/j.pscychresns.2006.12.003","journal-title":"Psychiatry Research: Neuroimaging"},{"issue":"10","key":"1181_CR25","doi-asserted-by":"publisher","first-page":"7340","DOI":"10.1002\/alz.14165","volume":"20","author":"WJ Jagust","year":"2024","unstructured":"Jagust, W. J., Koeppe, R. A., Rabinovici, G. D., Villemagne, V. L., Harrison, T. M., & Landau, S. M. (2024). The ADNI PET Core at 20. Alzheimers Dement, 20(10), 7340\u20137349. https:\/\/doi.org\/10.1002\/alz.14165","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1181_CR26","doi-asserted-by":"publisher","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","volume":"2","author":"KA Johnson","year":"2012","unstructured":"Johnson, K. A., Fox, N. C., Sperling, R. A., & Klunk, W. E. (2012). Brain imaging in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine, 2(4), a006213. https:\/\/doi.org\/10.1101\/cshperspect.a006213","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"1181_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179540","author":"V Kumar","year":"2022","unstructured":"Kumar, V., Kim, S. H., & Bishayee, K. (2022). Dysfunctional glucose metabolism in Alzheimer\u2019s disease onset and potential pharmacological interventions. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms23179540","journal-title":"International Journal of Molecular Sciences"},{"key":"1181_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.626636","volume":"15","author":"N Kyrtata","year":"2021","unstructured":"Kyrtata, N., Emsley, H. C., Sparasci, O., Parkes, L. M., & Dickie, B. R. (2021). A systematic review of glucose transport alterations in Alzheimer\u2019s disease. Frontiers in Neuroscience, 15, Article 626636.","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"1181_CR29","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1038\/tp.2016.296","volume":"7","author":"E Lauretti","year":"2017","unstructured":"Lauretti, E., Li, J., Di Meco, A., & Pratic\u00f2, D. (2017). Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model. Translational Psychiatry, 7(1), e1020\u2013e.","journal-title":"Translational Psychiatry"},{"key":"1181_CR30","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.50804","author":"HL Li","year":"2020","unstructured":"Li, H. L., & van Rossum, M. C. (2020). Energy efficient synaptic plasticity. eLife. https:\/\/doi.org\/10.7554\/eLife.50804","journal-title":"eLife"},{"issue":"4","key":"1181_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112335","volume":"42","author":"H Li","year":"2023","unstructured":"Li, H., Guglielmetti, C., Sei, Y. J., Zilberter, M., Le Page, L. M., Shields, L., et al. (2023). Neurons require glucose uptake and glycolysis in vivo. Cell Reports, 42(4), Article 112335. https:\/\/doi.org\/10.1016\/j.celrep.2023.112335","journal-title":"Cell Reports"},{"issue":"3","key":"1181_CR32","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41380-023-02376-6","volume":"29","author":"S Lista","year":"2024","unstructured":"Lista, S., Santos-Lozano, A., Emanuele, E., Mercuri, N. B., Gabelle, A., L\u00f3pez-Ortiz, S., et al. (2024). Monitoring synaptic pathology in Alzheimer\u2019s disease through fluid and PET imaging biomarkers: A comprehensive review and future perspectives. Molecular Psychiatry, 29(3), 847\u201357.","journal-title":"Molecular Psychiatry"},{"key":"1181_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fnagi.2017.00109","volume":"9","author":"D L\u00f3pez-Sanz","year":"2017","unstructured":"L\u00f3pez-Sanz, D., Bru\u00f1a, R., Garc\u00e9s, P., Mart\u00edn-Buro, M. C., Walter, S., Delgado, M. L., et al. (2017). Functional Connectivity Disruption in Subjective Cognitive Decline and Mild Cognitive Impairment: A Common Pattern of Alterations. Frontiers In Aging Neuroscience, 9, 109. https:\/\/doi.org\/10.3389\/fnagi.2017.00109","journal-title":"Frontiers In Aging Neuroscience"},{"key":"1181_CR34","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3740461","author":"KB Magalingam","year":"2018","unstructured":"Magalingam, K. B., Radhakrishnan, A., Ping, N. S., & Haleagrahara, N. (2018). Current concepts of neurodegenerative mechanisms in Alzheimer\u2019s disease. BioMed Research International. https:\/\/doi.org\/10.1155\/2018\/3740461","journal-title":"BioMed Research International"},{"key":"1181_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.neuroimage.2018.04.048","volume":"176","author":"R Marchitelli","year":"2018","unstructured":"Marchitelli, R., Aiello, M., Cachia, A., Quarantelli, M., Cavaliere, C., Postiglione, A., et al. (2018). Simultaneous resting-state FDG-PET\/fMRI in Alzheimer disease: Relationship between glucose metabolism and intrinsic activity. NeuroImage, 176, 246\u201358.","journal-title":"NeuroImage"},{"issue":"7","key":"1181_CR36","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology, 34(7), 939\u2013944. https:\/\/doi.org\/10.1212\/wnl.34.7.939","journal-title":"Neurology"},{"issue":"1","key":"1181_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cns.13050","volume":"25","author":"S Merlo","year":"2019","unstructured":"Merlo, S., Spampinato, S. F., & Sortino, M. A. (2019). Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer\u2019s Disease? Cns Neuroscience & Therapeutics, 25(1), 5\u201313. https:\/\/doi.org\/10.1111\/cns.13050","journal-title":"Cns Neuroscience & Therapeutics"},{"key":"1181_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102335","volume":"98","author":"M Mian","year":"2024","unstructured":"Mian, M., Tahiri, J., Eldin, R., Altabaa, M., Sehar, U., & Reddy, P. H. (2024). Overlooked cases of mild cognitive impairment: Implications to early Alzheimer\u2019s disease. Ageing Research Reviews, 98, Article 102335. https:\/\/doi.org\/10.1016\/j.arr.2024.102335","journal-title":"Ageing Research Reviews"},{"issue":"2","key":"1181_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/S1041610296002578","volume":"8","author":"RC Mohs","year":"1996","unstructured":"Mohs, R. C. (1996). The Alzheimer\u2019s disease assessment scale. International psychogeriatrics, 8(2), 195\u2013203.","journal-title":"International psychogeriatrics"},{"key":"1181_CR40","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","volume":"32","author":"L Mosconi","year":"2005","unstructured":"Mosconi, L. (2005). Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease: FDG-PET studies in MCI and AD. European journal of nuclear medicine and molecular imaging, 32, 486\u2013510.","journal-title":"European journal of nuclear medicine and molecular imaging"},{"key":"1181_CR41","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","volume":"36","author":"L Mosconi","year":"2009","unstructured":"Mosconi, L., Mistur, R., Switalski, R., Tsui, W. H., Glodzik, L., Li, Y., et al. (2009). FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease. European journal of nuclear medicine and molecular imaging, 36, 811\u2013822.","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"8","key":"1181_CR43","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/brain\/aww108","volume":"139","author":"H Oh","year":"2016","unstructured":"Oh, H., Madison, C., Baker, S., Rabinovici, G., & Jagust, W. (2016). Dynamic relationships between age, amyloid-\u03b2 deposition, and glucose metabolism link to the regional vulnerability to Alzheimer\u2019s disease. Brain, 139(8), 2275\u201389. https:\/\/doi.org\/10.1093\/brain\/aww108","journal-title":"Brain"},{"issue":"3","key":"1181_CR44","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1212\/wnl.0000000000201417","volume":"100","author":"A \u00d6hrfelt","year":"2023","unstructured":"\u00d6hrfelt, A., Benedet, A. L., Ashton, N. J., Kvartsberg, H., Vandijck, M., Weiner, M. W., et al. (2023). Association of CSF GAP-43 with the rate of cognitive decline and progression to dementia in amyloid-positive individuals. Neurology, 100(3), e275\u2013e85. https:\/\/doi.org\/10.1212\/wnl.0000000000201417","journal-title":"Neurology"},{"key":"1181_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2026.1731771","volume":"20","author":"Y Pang","year":"2026","unstructured":"Pang, Y., Yang, J., Liu, J., Xie, Z., & Wang, J. (2026). Metabolic interactions in the brain: The crucial roles of neurons, astrocytes, and microglia in health and disease. Frontiers in Neuroscience, 20, Article 1731771. https:\/\/doi.org\/10.3389\/fnins.2026.1731771","journal-title":"Frontiers in Neuroscience"},{"key":"1181_CR46","first-page":"1","volume":"11","author":"L Parnetti","year":"2019","unstructured":"Parnetti, L., Chipi, E., Salvadori, N., D\u2019Andrea, K., & Eusebi, P. (2019). Prevalence and risk of progression of preclinical Alzheimer\u2019s disease stages: A systematic review and meta-analysis. Alzheimer\u2019s research & therapy, 11, 1\u201313.","journal-title":"Alzheimer\u2019s research & therapy"},{"key":"1181_CR47","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/b978-0-12-819410-2.00022-9","volume":"184","author":"S Pelucchi","year":"2022","unstructured":"Pelucchi, S., Gardoni, F., Di Luca, M., & Marcello, E. (2022). Synaptic dysfunction in early phases of Alzheimer\u2019s Disease. Handbook Of Clinical Neurology, 184, 417\u2013438. https:\/\/doi.org\/10.1016\/b978-0-12-819410-2.00022-9","journal-title":"Handbook Of Clinical Neurology"},{"key":"1181_CR48","doi-asserted-by":"publisher","first-page":"154869","DOI":"10.1016\/j.metabol.2021.154869","volume":"123","author":"W Peng","year":"2021","unstructured":"Peng, W., Tan, C., Mo, L., Jiang, J., Zhou, W., Du, J., et al. (2021). Glucose transporter 3 in neuronal glucose metabolism: Health and diseases. Metabolism, 123, 154869. https:\/\/doi.org\/10.1016\/j.metabol.2021.154869","journal-title":"Metabolism"},{"issue":"3","key":"1181_CR49","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., et al. (2010). Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): Clinical characterization. Neurology, 74(3), 201\u2013209. https:\/\/doi.org\/10.1212\/WNL.0b013e3181cb3e25","journal-title":"Neurology"},{"issue":"1","key":"1181_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20324-2","volume":"12","author":"Q Qiang","year":"2022","unstructured":"Qiang, Q., Skudder-Hill, L., Toyota, T., Wei, W., & Adachi, H. (2022). CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer\u2019s disease. Scientific Reports, 12(1), Article 17392. https:\/\/doi.org\/10.1038\/s41598-022-20324-2","journal-title":"Scientific Reports"},{"issue":"1","key":"1181_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"A-C Raulin","year":"2022","unstructured":"Raulin, A-C., Doss, S. V., Trottier, Z. A., Ikezu, T. C., Bu, G., & Liu, C-C. (2022). ApoE in Alzheimer\u2019s disease: Pathophysiology and therapeutic strategies. Molecular Neurodegeneration, 17(1), 72. https:\/\/doi.org\/10.1186\/s13024-022-00574-4","journal-title":"Molecular Neurodegeneration"},{"issue":"4","key":"1181_CR52","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3233\/JAD-220515","volume":"90","author":"F Roveta","year":"2022","unstructured":"Roveta, F., Cermelli, A., Boschi, S., Ferrandes, F., Grassini, A., Marcinn\u00f2, A., et al. (2022). Synaptic Proteins as Fluid Biomarkers in Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer\u2019s Disease, 90(4), 1381\u20131393.","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"1181_CR53","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.cortex.2024.07.004","volume":"179","author":"E Salmon","year":"2024","unstructured":"Salmon, E., Collette, F., & Bastin, C. (2024). Cerebral glucose metabolism in Alzheimer\u2019s disease. Cortex; A Journal Devoted To The Study Of The Nervous System And Behavior, 179, 50\u201361. https:\/\/doi.org\/10.1016\/j.cortex.2024.07.004","journal-title":"Cortex; A Journal Devoted To The Study Of The Nervous System And Behavior"},{"issue":"1","key":"1181_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jalz.2018.08.006","volume":"15","author":"\u00c5 Sandelius","year":"2019","unstructured":"Sandelius, \u00c5., Portelius, E., K\u00e4ll\u00e9n, \u00c5., Zetterberg, H., Rot, U., Olsson, B., et al. (2019). Elevated CSF GAP-43 is Alzheimer\u2019s disease specific and associated with tau and amyloid pathology. Alzheimer\u2019s & Dementia, 15(1), 55\u201364. https:\/\/doi.org\/10.1016\/j.jalz.2018.08.006","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"8","key":"1181_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14897","volume":"30","author":"F Sayehmiri","year":"2024","unstructured":"Sayehmiri, F., Motamedi, F., Batool, Z., Naderi, N., Shaerzadeh, F., Zoghi, A., et al. (2024). Mitochondrial plasticity and synaptic plasticity crosstalk; In health and Alzheimer\u2019s disease. CNS Neuroscience & Therapeutics, 30(8), Article e14897. https:\/\/doi.org\/10.1111\/cns.14897","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"5","key":"1181_CR56","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-011-0808-0","volume":"121","author":"LM Shaw","year":"2011","unstructured":"Shaw, L. M., Vanderstichele, H., Knapik-Czajka, M., Figurski, M., Coart, E., Blennow, K., et al. (2011). Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI. Acta neuropathologica, 121(5), 597\u2013609.","journal-title":"Acta neuropathologica"},{"issue":"1","key":"1181_CR57","doi-asserted-by":"publisher","first-page":"W76","DOI":"10.2214\/AJR.13.12363","volume":"204","author":"VKN Shivamurthy","year":"2014","unstructured":"Shivamurthy, V. K. N., Tahari, A. K., Marcus, C., & Subramaniam, R. M. (2014). Brain FDG PET and the Diagnosis of Dementia. American Journal of Roentgenology, 204(1), W76\u2013W85. https:\/\/doi.org\/10.2214\/AJR.13.12363","journal-title":"American Journal of Roentgenology"},{"issue":"4","key":"1181_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.70180","volume":"46","author":"S Soltani","year":"2025","unstructured":"Soltani, S., Dolatshahi, M., Soltani, S., Khazaei, K., Rahmani, M., & Raji, C. A. (2025). Relationships between brain glucose metabolism patterns and impaired glycemic status: A systematic review of FDG-PET studies with a focus on Alzheimer\u2019s disease. Human Brain Mapping, 46(4), Article e70180. https:\/\/doi.org\/10.1002\/hbm.70180","journal-title":"Human Brain Mapping"},{"key":"1181_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00288","volume":"11","author":"S Sonnay","year":"2017","unstructured":"Sonnay, S., Gruetter, R., & Duarte, J. M. N. (2017). How energy metabolism supports cerebral function: Insights from (13)C magnetic resonance studies in vivo. Frontiers in Neuroscience, 11, Article 288. https:\/\/doi.org\/10.3389\/fnins.2017.00288","journal-title":"Frontiers in Neuroscience"},{"issue":"7","key":"1181_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.638","volume":"5","author":"C Yang","year":"2024","unstructured":"Yang, C., Liu, G., Chen, X., & Le, W. (2024). Cerebellum in Alzheimer\u2019s disease and other neurodegenerative diseases: An emerging research frontier. MedComm, 5(7), Article e638.","journal-title":"MedComm"},{"key":"1181_CR61","doi-asserted-by":"crossref","unstructured":"Zhang, K., Mizuma, H., Zhang, X., Takahashi, K., Jin, C., Song, F. (2021). PET imaging of neural activity, \u03b2-amyloid, and tau in normal brain aging. European Journal of Nuclear Medicine and Molecular Imaging. :1\u201313.","DOI":"10.1007\/s00259-021-05230-5"},{"key":"1181_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.662242","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Alshakhshir, N., & Zhao, L. (2021). Glycolytic metabolism, brain resilience, and Alzheimer\u2019s disease. Frontiers in Neuroscience, 15, Article 662242. https:\/\/doi.org\/10.3389\/fnins.2021.662242","journal-title":"Frontiers in Neuroscience"}],"container-title":["Brain Imaging and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11682-026-01181-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11682-026-01181-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11682-026-01181-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:18:22Z","timestamp":1788855502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11682-026-01181-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":61,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1181"],"URL":"https:\/\/doi.org\/10.1007\/s11682-026-01181-3","relation":{},"ISSN":["1931-7565"],"issn-type":[{"value":"1931-7565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted using ADNI data. The ADNIstudy is ethically approved and operated in accordance with the Declaration of Helsinki, 1964.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"112"}}